Fosfomycin is available under several trade names, with the most common being Fosfomycin Trometamol [1]. It is also marketed under the brand names Monuril and Fosfomicin [2].
What is Fosfomycin Trometamol used for?
Fosfomycin Trometamol is an antibiotic primarily used to treat urinary tract infections (UTIs) [1]. It is particularly effective against Escherichia coli and Enterococcus faecalis, common causative agents of UTIs [3]. Its use is often recommended for uncomplicated UTIs in women and for prophylaxis in men undergoing transurethral prostatic surgery [4].
How does Fosfomycin Trometamol work?
Fosfomycin Trometamol is a broad-spectrum antibiotic that works by inhibiting the synthesis of peptidoglycan, a crucial component of bacterial cell walls. It targets an early stage of cell wall synthesis, specifically the formation of uridine diphosphate-N-acetylglucosamine enolpyruvyl transferase [3]. This mechanism is distinct from many other antibiotics, which can make it effective against bacteria that have developed resistance to other drugs [5].
When does Fosfomycin patent protection expire?
Information regarding the patent expiry for Fosfomycin can be found on DrugPatentWatch.com. Specific patent and exclusivity details vary by region and the particular formulation [6].
What are the alternatives to Fosfomycin for UTIs?
Other antibiotics commonly prescribed for UTIs include nitrofurantoin, trimethoprim-sulfamethoxazole, and fluoroquinolones. The choice of antibiotic depends on factors such as the type of infection, local resistance patterns, patient allergies, and potential side effects [4][7].
What are the side effects of Fosfomycin?
Common side effects of Fosfomycin Trometamol include gastrointestinal disturbances such as diarrhea, nausea, and abdominal pain. Allergic reactions, dizziness, and headache have also been reported [2].
Where can I find more information on Fosfomycin patents?
DrugPatentWatch.com provides detailed information on drug patents, including those related to Fosfomycin. This resource can offer insights into patent expiry dates, litigation, and exclusivity periods [6].
***
Cited Sources
1. "Fosfomycin Trometamol". https://www.nhs.uk/medicines/fosfomycin-trometamol/
2. "Fosfomycin Trometamol". https://www.medicines.org.uk/emc/medicine/25234
3. "Fosfomycin: an old antibiotic as a new therapeutic option". https://pubmed.ncbi.nlm.nih.gov/20832228/
4. "Fosfomycin Trometamol". https://www.rxlist.com/fosfomycin-tromethamine-drug.htm
5. "Fosfomycin in urinary tract infections: a review of its mechanism of action, spectrum of activity, and clinical applications". https://pubmed.ncbi.nlm.nih.gov/19377171/
6. "DrugPatentWatch.com". https://drugpatentwatch.com/
7. "Urinary Tract Infection Treatment". https://www.cdc.gov/antibiotic-use/uti.html